Civi Biopharma Revenue, Growth & Competitor Profile

Company Profile & Annual Report for Civi Biopharma

Access the complete profile.

Civi Biopharma Fast Facts

Revenue	$1 - $10 million    See Exact Annual Revenue
Employees	1 - 10Exact Company Size
Primary Industry	325411 Medicinal & Botanical Manufacturing
Address	5425 Wisconsin Avenue 6th Floor Chevy Chase, MD 20815

Note: Revenues for privately held companies are statistical evaluations.


Civi Biopharma's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Civi Biopharma's annual revenues are $1 - $10 million (see exact revenue data)
• What industry is the company in?
  • Civi Biopharma is classified as operating in the Medicinal & Botanical Manufacturing industry, NAICS Code 325411.

Civi Biopharma Annual Revenue and Growth Rate

Civi Biopharma	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2025	$1 - $10 million Details in Premium Report
2024
2023
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Civi Biopharma's revenues are gauged from an analysis of company filings.

Civi Biopharma's Income Statement (based on Industry Averages)

Civi Biopharma P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Trademark Applications

Trademark applications show the products and services that Civi Biopharma is developing and marketing. Civi Biopharma doesn't have any recent trademark applications, indicating Civi Biopharma is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
CIVI BIOPHARMA Pharmaceutical preparations for the treatment of cardiovascular, metabolic and autoimmune diseases and related disorders	02/16/2018

See all trademarks and details in the Full Report.

Market Share of Civi Biopharma's Largest Competitors

A competitive analysis shows these companies are in the same general field as Civi Biopharma, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
XYMOGEN	Orlando, FL	100
AVANTI NUTRITIONAL LABORATORIES	Miami Lakes, FL	37
NUTRITION FORMULATORS	Miramar, FL	36
RTPR	Cabot, AR	33
INTEGRATED BOTANICS	Fort Worth, TX	29
COSMAX NBT USA	Garland, TX	29
CJB INDUSTRIES	Valdosta, GA	28
ALTERNATIVE LABORATORIES	Naples, FL	28
S&B PHARMA	Azusa, CA	28

Nearby Competitors

These companies are similar in business line and location to Civi Biopharma. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
EMERGENT BIOSOLUTIONS	Gaithersburg, MD	100
SUPERNUS PHARMACEUTICALS	Rockville, MD	62
AURINIA PHARMA US	Rockville, MD	28
VIGENE BIOSCIENCES	Rockville, MD	15
ORIGENE TECHNOLOGIES	Rockville, MD	13
NEUMODX	Germantown, MD	13

Other Companies at 5425 Wisconsin Avenue, Chevy Chase MD

Company	Headquarters	Revenue ($ MM)
VISUAL CONNECTIONS	Chevy Chase, MD	100
ARLINGTON MANAGEMENT EMPLOYESS	Chevy Chase, MD	35
BLACKSTREET CAPITAL MANAGEMENT	Chevy Chase, MD	31
HEART FAILURE SOCIETY OF AMERICA	Chevy Chase, MD	22
STRATEGI CONSULTING	Chevy Chase, MD	18

Future Competition: Civi Biopharma's Fastest Growing Competitors

These companies are in the same general field as Civi Biopharma and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)